Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Molzyme Wins CE-IVD Marking for Pathogen Test

Molzyme Wins CE-IVD Marking for Pathogen Test

Nov 09, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Molzym announced on Thursday that it has received CE-IVD marking for its Micro-Dx microbial DNA isolation and direct PCR test for routine pathogen diagnosis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Molecular Diagnostics

  1. President Biden Announces Plan to Expand SARS-CoV-2 Testing, Increase Capacity

  2. Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

  3. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

  4. Lucira Health Files for $115M IPO

  5. Molzym, Fraunhofer Developing Rapid Direct-From-Sample Sepsis Diagnostic Platform and Test

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.